There are many myths and misconceptions surrounding erectile dysfunction which are causing so many people avoid seeking medical attention endagering their lives.
Continue readingPost Category → #ShimClinic
65% of Gay and Bisexual Men Not Using Condoms During Sex
The number of men in the UK using condoms when having sex with other men is gradually reducing due to use of HIV PrEP and dating apps.
Continue readingNew York City Health Department Using Emojis in Campaign to Encourage STI Testing
New York City is using emojis such as the eggplant in a new campaign aimed to encourage youths to go for STD testing as new infection rates continue to soar.
Continue readingWhy Men Don’t Talk to Doctors about Erectile Dysfunction
Despite increasd rates of erectile dysfuntion among men aged 40 years and above, men are refusing to talk about it or seek medical attention risking their lives.
Continue readingErectile Dysfunction Drugs Don’t Cause Melanoma
A new study has found no connection between erectile dysfunction drugs such as viagra and melanoma a deadly for of skin cancer.
Continue readingOne in Seven Gay and Bi Men in London Lives With HIV
One in seven gay and bi men in London is currently living with HIV. New PrEP trial is hoped to decrease the number of new HIV infections among this group.
Continue readingHealth Alert Issued As Gonorrhea Rates Increase in Wyoming State
The Department of Health has sent out a health alert following a worrisome increament in new cases of gonorrhea in Wyoming state in recent years.
Continue readingDrop in Single Men Using Contraception as STD Rates Go Up
Single men in the United States are shunning the use of contraceptives including condoms resulting in increased rates of new STD infections.
Continue readingExperts Believe Online Clinics Will Increase Usage of PrEP
Online HIV pre-exposure prophylaxis (PrEP) providers could tremendously increase access to the life saving drug across the US.
Continue readingWomen Responding Well to PrEP Variation to Popular Truvada
A new HIV pre-exposure prophylaxis (PrEP) drug has been found to be safe and well tolerated among women bringing the number of PrEP pills in the market to two.
Continue reading